2042-2827 Screening compound: N-(5-methylpyridin-2-yl)-[1,1'-biphenyl]-4-carboxamide

2042-2827 Screening compound: N-(5-methylpyridin-2-yl)-[1,1'-biphenyl]-4-carboxamide
2042-2827 Screening compound: N-(5-methylpyridin-2-yl)-[1,1'-biphenyl]-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 2042-2827
N-(5-methylpyridin-2-yl)-[1,1'-biphenyl]-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2042-2827

Molecular Formula

C19H16N2O (C19 H16 N2 O)

Compound Name

N-(5-methylpyridin-2-yl)-[1,1'-biphenyl]-4-carboxamide

IUPAC name

N-(5-methylpyridin-2-yl)-[11'-biphenyl]-4-carboxamide

SMILES

Cc(cc1)cnc1NC(c(cc1)ccc1-c1ccccc1)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

288.35

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

3

Partition Coefficient, logP

4.859

Distribution Coefficient, logD

4.853

Water Solubility, LogSw

-4.62

Polar Surface Area

32.763

Acid Dissociation Constant (pKa)

9.26

Base Dissociation Constant (pKb)

3.94

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

5.30

2042-2827 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Proline Kinase Library (2105 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Nervous system
  • Male
  • Female
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
  • Kinases
  • Proteases
  • Kinases

References: we are preparing a list of scientific research reports with 2042-2827 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2042-2827?
Check Price and Availability of 2042-2827, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2042-2827 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2042-2827
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2042-2827
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2042-2827 available by request